GlassScriptPhysician profile
John Leslie Lederer
NPI 1740253327
$2,549.21
in general payments reported to CMS, 2019-2025
23 companies · $526 in 2025
The $526 reported for 2025 was more than what 75% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $111 · 2021: $321 · 2022: $425 · 2023: $619 · 2024: $286 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $279.48 | 2020-2022 | |
| Elekta, INC. | $273.06 | 2023-2025 | Elekta Medical Linear Accelerator |
| Astrazeneca Pharmaceuticals LP | $242.70 | 2020-2025 | Imfinzi |
| E.R. Squibb & Sons, L.L.C. | $220.52 | 2019-2025 | Opdivo |
| Pfizer INC. | $200.10 | 2020-2024 | |
| Siemens Medical Solutions USA, INC. | $199.94 | 2022-2025 | Varian Ethos Treatment Planning, Aria Radiation Therapy Management Software, Truebeam |
| Bayer Healthcare Pharmaceuticals INC. | $166.55 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $158.97 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Novartis Pharmaceuticals Corporation | $154.86 | 2021-2025 | |
| Boston Scientific Corporation | $136.40 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $84.60 | 2025 | Balversa, Akeega, Erleada |
| Janssen Biotech, INC. | $70.65 | 2021-2023 | Erleada |
| Teleflex LLC | $67.81 | 2025 | Barrigel |
| Carbofix Spine INC | $51.94 | 2019 | |
| Varian Medical Systems, INC. | $39.19 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $32.25 | 2023 | Stimufend |
| Reflexion Medical, INC. | $31.41 | 2023 | Reflexion Medical Radiotherapy System |
| Genzyme Corporation | $29.37 | 2021 | |
| Visionrt, INC. | $26.56 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $25.05 | 2022 | |
| Servier Pharmaceuticals LLC | $23.25 | 2024 | |
| Medtronic, INC. | $19.39 | 2025 | Superlock |
| Novocure INC. | $15.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lederer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.